IRCT20201216049736N1招募中3 期
Clinical trial comparing the efficacy and safety of N-acetylcysteine and amantadine on fatigue and disability and quality of life of patients with MS
Vice Chancellor for Research and Technology, Ahvaz Jundishapur University of Medical Sciences0 个研究点目标入组 112 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 112
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 50 years（—）
- 性别
- All
入选标准
- •Patients with definitive diagnosis of MS aged 18 to 50 years
- •Be in the offensive phase (at least one month after the attack)
- •Disability rate according to EDSS criteria is between 1 to 5.5.
- •Fatigue is 4 or higher according to the FSS criteria.
- •If interferon is used to treat multiple sclerosis, at least 6 months have passed since the start of this drug.
排除标准
- •History of corticosteroid use during the month before treatment
- •Taking supplements or drugs with antioxidant properties such as vitamins E and C, zinc, melatonin
- •Taking medications that cause fatigue and drowsiness (such as benzodiazepines, tricyclic antidepressants,sedatives, anticonvulsants)
- •Taking stimulant drugs, amantadine, dopaminergic drugs
- •Pregnancy and lactation
- •History of NAC allergy or any side effects
- •Existence of depression (according to Beck questionnaire)
- •Accompanying medical conditions that can cause fatigue, such as: sleep disorders, heart failure, anemia, hypothyroidism and ....
研究者
相似试验
尚未招募
不适用
Study on efficacy and safety of the slow release drug delivery device PF-72Diseases of the digestive systemKCT0004388TGelBio Co., Ltd.108
进行中（未招募）
不适用
A clinical trial comparing efficacy and safety of insulin degludec/liraglutide (IDegLira) in subjects with type 2 diabetes mellitus using two different titration algorithmsMedDRA version: 17.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861Diabetes Mellitus, Type 2EUCTR2012-004625-25-ATovo Nordisk A/S416
进行中（未招募）
不适用
A clinical trial comparing efficacy and safety of insulin degludec/liraglutide (IDegLira) in subjects with type 2 diabetes mellitus using two different titration algorithmsDiabetes Mellitus, Type 2MedDRA version: 17.0Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2012-004625-25-HUovo Nordisk A/S416
进行中（未招募）
1 期
A clinical trial comparing efficacy and safety of insulin degludec/liraglutide (IDegLira) in subjects with type 2 diabetes mellitus using two different titration algorithmsMedDRA version: 18.0Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861Diabetes Mellitus, Type 2EUCTR2012-004625-25-CZovo Nordisk A/S416
进行中（未招募）
不适用
A clinical trial comparing efficacy and safety of insulin degludec/liraglutide (IDegLira) in subjects with type 2 diabetes mellitus using two different titration algorithmsDiabetes Mellitus, Type 2EUCTR2012-004625-25-SKovo Nordisk A/S416